20 (AIDX) Cash & Equivalents (2024 - 2026)

20 (AIDX) posted Cash & Equivalents of $4.2 million for Q1 2026, up 311.22% on a QoQ basis from $1.0 million in Q4 2025.

20 (AIDX) Cash & Equivalents (2024 - 2026) Analysis & Trends

20's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $4.2 million for Q1 2026.

  • Quarterly Cash & Equivalents changed N/A year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 million, down 42.49% from the prior year.
  • Cash & Equivalents was $4.2 million for Q1 2026 at 20, up from $1.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.2 million in Q1 2026 and bottomed at $1.0 million in Q4 2025.
  • A 3-year average of $2.3 million and a median of $1.8 million in 2024 frame the typical range for Cash & Equivalents.
  • Peak annual rise in Cash & Equivalents reached 42.49% in 2025, while the deepest fall reached 42.49% in 2025.
  • 20's Cash & Equivalents stood at $1.8 million in 2024, then plunged by 42.49% to $1.0 million in 2025, then soared by 311.22% to $4.2 million in 2026.
  • Business Quant data shows AIDX's Cash & Equivalents at $4.2 million in Q1 2026, $1.0 million in Q4 2025, and $1.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 6.80 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 2.88 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.95 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.45 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.03 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.29 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 557.00 Mn
10 20 3.91 Mn -313,912.28 62,884.00 4.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.22 Mn
Dec 31, 2025 1.03 Mn
Dec 31, 2024 1.78 Mn